Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Disease progression: Divergent paths

Not everyone with a fatty liver goes on to develop more advanced disease. Understanding what triggers the progression could lead to better treatments.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Authors

Additional information

This article is part of Nature Outlook: Fatty liver disease, an editorially independent supplement produced with the financial support of third parties. About this content.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

DeWeerdt, S. Disease progression: Divergent paths. Nature 551, S92–S93 (2017). https://doi.org/10.1038/d41586-017-06925-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/d41586-017-06925-2

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing